Sunday, April 28, 2024
4/28/2024
Summary/Abstract PAHC is seeking approval from the U.S. Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM) of Terramycin® 200 for Fish Type A medicated article, containing the active pharmaceutical ingredient (API) oxytetracycline, for use in penaeid shrimp. The proposed indication is for the control of mortality in penaeid shrimp due to necrotizing hepatopancreatits (NHP) associated with Hepatobacter penaei. The work involved will include environmental assessment, conditions of use of the drug, exposure assessment, effects assessment, risk characterization, and conclusions.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
